miR-150 |
ACOX1, PPARA, ADCY1, ADCY2, ADCY5, ADCY6, GABBR1, CNGB1, ADORA1, ATP2B1, BDNF, ATP2B3, ATP2B4, GRIN2B, TIAM1, PDE4A, PAK1, RAPGEF3, |
cAMP signaling pathway |
|
FGF7, ZAK, PDGFB, FGF9, GNA12, FGF12, MAX, BDNF, MAPT, PAK1, FGF1, IL1A, AKT3, AKT2, PRKCA, BRAF, CACNG8, TP53, CACNG4, CACNG2, PRKCB, |
MAPK signaling pathway |
|
GRB2, CAMK2G, STAT5B, ELK1, PAK3, CAMK2B, SHC1, PAK1, SHC3, PIK3R3, AKT3, PIK3R1, PIK3R2, SHC4, AKT2 |
ErbB signaling pathway |
|
PRKCA, TNF, BRAF, STK11, PIK3CB, IGF1, RICTOR, PRKCB, EIF4B, RPS6KA6, RPS6KA3, AKT1S1, TSC1, ULK1, ULK2, ULK3, PRKAA2, PIK3R3, AKT3, PIK3R1, AKT2, PIK3R2 |
mTOR signaling pathway |
|
E2F3, BRAF, GRB2, PIK3CB, TGFBR1, CBL, STAT5B, TP53, SMAD4, CDK4, CBLB, CCND1, CDKN1B, ARAF, MDM2, SHC1, PIK3R3, SHC3, CRK, PIK3R1, AKT3, AKT2, PIK3R2, SHC4 |
Chronic myeloid leukemia signaling pathway |
|
ADCY1, PPARD, E2F3, ADCY2, FGF7, PDGFB, FGF9, ADCY5, ADCY6, STAT5B, GNA12, SPI1, FGF12, CTNNB1, MAX, PAX8, SLC2A1, FGF1 |
Pathway in cancer |